US FDA Approves Gilead’s Veklury (Remdesivir) Covid-19 Drug For Young Children
The Food and Drug Administration (FDA) of the United States has granted approval for Veklury (remdesivir), a covid-19 drug developed by Gilead for the purpose of treating the infants and children over the age period of 28 days. The decision of the US FDA has been making the drug the very first approved corona virus […]
Continue Reading